Tag:
J. Michael Pearson
Latest Headlines
Latest Headlines
Key Valeant drug fails mid-stage pain trial
Valeant Pharmaceuticals has won rare praise for designing a pay package for its CEO that rewards long-term success. Ironically, the company reported a key failure in a mid-stage trial the same day
Valeant chops workforce in restructuring
In an effort to bring expenses in line with revenues, Valeant is cutting 130 workers in the U.S. and Mexico. In addition, headcount will be further reduced by 1,250 positions as it divests its
